Physician profile
Mark A Steiner
NPI 1023012093
$32,427.73
in general payments reported to CMS, 2019-2025
39 companies · $14K in 2025
The $14K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,531 · 2020: $1,251 · 2021: $938 · 2022: $6,074 · 2023: $2,970 · 2024: $5,398 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K · Travel and Lodging: $632 · Gift: $237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,433.63 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,331.25 |
| Travel and Lodging | $631.92 |
| Gift | $237.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $14,271.39 | 2021-2025 | Symplicity G3, Resolute Onyx, Corevalve Evolut R |
| Cardiovascular Systems INC. | $4,908.76 | 2019-2023 | Diamondback Coronary, Diamondback Peripheral |
| Abiomed | $3,074.87 | 2019-2025 | Impella |
| Boston Scientific Corporation | $1,666.09 | 2019-2025 | Watchman Access System, Bodyguardian, Avvigo Guidance System |
| Shockwave Medical, INC | $1,271.03 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Kestra Medical Technology Services, INC. | $956.49 | 2023-2025 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $526.54 | 2023-2025 | Camzyos, Eliquis |
| Abbott Laboratories | $525.89 | 2019-2025 | Diamondback Coronary, Cardiomems, Dragonfly Opstar |
| Janssen Pharmaceuticals, INC | $509.14 | 2019-2024 | Xarelto |
| Amgen INC. | $508.37 | 2020-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $503.41 | 2019-2025 | Wainua, Farxiga |
| Medtronic Vascular, INC. | $495.18 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $353.23 | 2019-2025 | Gore Acuseal Cardiovascular Patch Vascular, Gore Viabahn Endoprosthesis With Heparin, Balloon Wire |
| Teleflex LLC | $320.45 | 2023-2025 | Guideliner, Turnpike, Vascband |
| Novartis Pharmaceuticals Corporation | $314.28 | 2023-2025 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $226.49 | 2021-2025 | Penumbra System, Indigo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $207.24 | 2024-2025 | Jardiance |
| Cvrx, INC. | $204.64 | 2025 | Barostim Neo System |
| Pfizer INC. | $188.26 | 2023-2024 | |
| Esperion Therapeutics, INC. | $159.24 | 2024-2025 | Nexletol |
| Biosense Webster, INC. | $158.72 | 2022-2024 | Nuvision Ice Catheter, Na |
| Impulse Dynamics (USA) INC. | $147.10 | 2022 | |
| Cardiva Medical, INC. | $123.80 | 2019-2020 | |
| Stryker Corporation | $116.69 | 2025 | Actishield |
| Alnylam Pharmaceuticals INC. | $113.68 | 2024-2025 | Onpattro |
| Novo Nordisk INC | $103.03 | 2023-2024 | Ozempic, Wegovy |
| Inari Medical, INC. | $95.05 | 2020-2021 | |
| Atricure, INC. | $72.35 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $55.34 | 2019-2025 | Lifevest |
| Cordis US Corp. | $36.93 | 2021-2023 | Mynx Control |
| Cook Medical LLC | $35.78 | 2020 | |
| Livanova USA, INC. | $30.84 | 2021 | |
| Ekos Corporation | $30.19 | 2019 | |
| Terumo Medical Corporation | $29.16 | 2022 | |
| Edwards Lifesciences Corporation | $25.72 | 2024 | |
| Bard Peripheral Vascular, INC. | $20.65 | 2019 | |
| Amarin Pharma, INC. | $16.02 | 2019 | |
| Lilly USA, LLC | $14.30 | 2024 | Zepbound, Mounjaro |
| Philips North America LLC | $11.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Steiner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.